House
May 27, 2020

To provide for quality assurance of COVID-19 reimbursements and reporting.

Summary

Official

This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test...

How would you vote on this bill?

Bill Progress

Bill has been introduced and assigned a number

Introduced(5/27/20)
Committee
Passed House
Passed Senate
President
Law

Sponsor

BP

Mr. Posey

(R) FL – 8

Topics

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 27, 2020